GlassScriptPhysician profile
Joshua M Aaron
NPI 1295852101
$8,703.98
in general payments reported to CMS, 2019-2025
24 companies · $254 in 2025
The $254 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $221 · 2020: $6,123 · 2021: $208 · 2022: $1,416 · 2023: $329 · 2024: $153 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $736.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $736.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,078.44 | 2019-2020 | |
| Tela Bio, INC. | $1,518.40 | 2019-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Ethicon US, LLC | $296.03 | 2019-2025 | Stratafix, Vistaseal, Ethicon |
| Allergan, INC. | $133.75 | 2019-2021 | |
| Glaxosmithkline, LLC. | $77.53 | 2022-2023 | Arexvy, Nucala |
| Polynovo North America LLC | $76.20 | 2021-2025 | Novosorb Btm |
| Kerecis Limited | $75.91 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Sirius Medical Systems | $63.94 | 2023 | Pintuition |
| Davol INC. | $48.60 | 2021 | |
| Baxter Healthcare | $30.62 | 2025 | Perclot |
| Takeda Pharmaceuticals U.S.A., INC. | $28.57 | 2025 | Gattex |
| Integra Lifesciences Corporation | $28.51 | 2021 | |
| Csl Behring | $28.18 | 2023 | Kcentra |
| Acera Surgical, INC. | $27.57 | 2025 | Restrata Wound Matrix |
| Zimmer Biomet Holdings, INC. | $26.26 | 2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $25.81 | 2022 | |
| Innovation Technologies INC | $23.16 | 2025 | Irrisept |
| Medtronic, INC. | $22.87 | 2021 | |
| Kls-Martin L.P. | $20.46 | 2019 | |
| Melinta Therapeutics, LLC | $18.74 | 2019 | |
| W. L. Gore & Associates, INC. | $14.79 | 2025 | Gore Synecor Biomaterial |
| Bioptics, INC. | $14.38 | 2019 | |
| Abbvie INC. | $14.10 | 2023 | Dalvance |
| Stryker Corporation | $11.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Aaron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.